DNA topoisomerase IIalpha (topo IIalpha) is an essential nuclear enzyme and its unique decatenation activity has been implicated in many aspects of chromosome dynamics such as chromosome replication and segregation during mitosis. Here we show that chromatin-associated protein HMGB1 (a member of the large family of HMG-box proteins with possible functions in DNA replication, transcription, recombination and DNA repair) promotes topo IIalpha-mediated catenation of circular DNA, relaxation of negatively supercoiled DNA and decatenation of kinetoplast DNA. HMGB1 interacts with topo IIalpha and this interaction, like the stimulation of the catalytic activity of the enzyme, requires both HMG-box domains of HMGB1. A mutant of HMGB1, which cannot change DNA topology stimulates DNA decatenation by topo IIalpha indistinguishably from the wild-type protein. Although HMGB1 stimulates ATP hydrolysis by topo IIalpha, the DNA cleavage is much more enhanced. The observed abilities of HMGB1 to interact with topo IIalpha and promote topo IIalpha binding to DNA suggest a mechanism by which HMGB1 stimulates the catalytic activity of the enzyme via enhancement of DNA cleavage.

Laboratory of Analysis of Chromosomal Proteins Academy of Sciences of the Czech Republic Institute of Biophysics Brno Czech Republic

Zobrazit více v PubMed

Wang JC. Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol. 2002;3:430–440. PubMed

Osheroff N, Zechiedrich EL, Gale KC. Catalytic function of DNA topoisomerase II. Bioessays. 1991;13:269–273. PubMed

Baldwin EL, Osherhoff N. Etoposide, topoisomerase II and cancer. Curr. Med. Chem. Anticancer Agents. 2005;5:363–372. PubMed

Denny WA. Emerging DNA toposomerase inhibitors as anticancer drugs. Expert Opin. Emerg. Drugs. 2004;9:105–133. PubMed

Agresti A, Bianchi ME. HMGB proteins and gene expression. Curr. Opin. Genet. Dev. 2003;13:170–178. PubMed

Bianchi ME. Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death. Trends Cell Biol. 2004;14:287–293. PubMed

Thomas JO, Travers AA. HMG1 and 2, and related ‘architectural’ DNA-binding proteins. Trends Biochem. Sci. 2001;26:167–174. PubMed

Štros M, Launholt D, Grasser KD. The HMG-box: a versatile protein domain occurring in a wide variety of DNA-binding proteins. Cell. Mol. Life Sci. 2007 in press (doi: 10.1007/s00018-007-7160-5) PubMed PMC

Paull TT, Haykinson MJ, Johnson RC. The nonspecific DNA-binding and -bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures. Genes Dev. 1993;7:1521–1534. PubMed

Pil PM, Chow CS, Lippard SJ. High-mobility-group 1 protein mediates DNA bending as determined by ring closures. Proc. Natl Acad. Sci. USA. 1993;90:9465–9469. PubMed PMC

Štros M, Muselíková-Polanská E, Pospíšilová Š, Strauss F. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops. Biochemistry. 2004;43:7215–7225. PubMed

Jaouen S, de Koning L, Gaillard C, Muselíková-Polanská E, Štros M, Strauss F. Determinants of specific binding of HMGB1 protein to hemicatenated DNA loops. J. Mol. Biol. 2005;353:822–837. PubMed

Sheflin LG, Spaulding SW. High mobility group protein 1 preferentially conserves torsion in negatively supercoiled DNA. Biochemistry. 1989;28:5658–5664. PubMed

Štros M, Štokrová J, Thomas JO. DNA looping by the HMG-box domains of HMG1 and modulation of DNA binding by the acidic C-terminal domain. Nucleic Acids Res. 1994;22:1044–1051. PubMed PMC

Calogero S, Grassi F, Aguzzi A, Voigtlander T, Ferrier P, Ferrari S, Bianchi ME. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat. Genet. 1999;22:276–280. PubMed

Jensen S, Andersen AH, Kjeldsen E, Biersack H, Olsen EHN, Andersen TB, Westergaard O, Jakobsen BK. Analysis of functional domain organization in DNA topoisomerase II from humans and Saccharomyces cerevisiae. Mol. Cell. Biol. 1996;16:3866–3877. PubMed PMC

Biersack H, Jensen S, Westergaard O. Rapid purification of DNA topoisomerase II containing a hexahistidine tag by metal ion affinity chromatography. In: Bjornsti M-A, Osheroff N, editors. Methods in Molecular Biology. Totowa, New Jersey: Humana Press; 1999. Vol. 94: Protocols in DNA Topology and Topoisomerases, Part I: DNA Topology and Enzymes, pp. 235–242. PubMed

Skouboe C, Bjergbaek L, Oestergaard VH, Larsen MK, Knudsen BR, Andersen AH. A human topoisomerase II alpha heterodimer with only one ATP binding site can go through successive catalytic cycles. J. Biol. Chem. 2003;278:5768–5774. PubMed

Shapiro TA, Klein VA, Englund PT. Isolation of kinetoplast DNA. In: Bjornsti M-A, Osheroff N, editors. Methods in Molecular Biology. Totowa, New Jersey: Humana Press; 1999. Vol. 94: Protocols in DNA Topology and Topoisomerases, Part I: DNA Topology and Enzymes, pp. 61–67. PubMed

Štros M, Muselíková E. A role of basic residues and the putative intercalating phenylalanine of the HMG-1 box B in DNA supercoiling and binding to four-way DNA junctions. J. Biol. Chem. 2000;275:35699–35707. PubMed

Štros M. DNA bending by the chromosomal protein HMG1 and its high mobility group box domains. Effect of flanking sequences. J. Biol. Chem. 1998;273:10355–10361. PubMed

Štros M, Ozaki T, Bačíková A, Kageyama H, Nakagawara A. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter. J. Biol. Chem. 2002;277:7157–7164. PubMed

West KL, Austin CA. Human DNA topoisomerase IIβ binds and cleaves four-way junction DNA in vitro. Nucleic Acids Res. 1999;27:984–992. PubMed PMC

Kingma PS, Fortune JM, Osheroff N. Topoisomerase II-catalyzed ATP hydrolysis as monitored by thin-layer chromatography. In: Osheroff N, Bjornsti M-A, editors. Methods in Molecular Biology. Totowa, New Jersey: Humana Press; 2001. Vol. 95: DNA Topoisomerase Protocols, Part II: Enzymology and Drugs, pp. 51–56. PubMed

Zechiedrich EL, Crisona NJ. Coating DNA with RecA protein to distinguish DNA path by electron microscopy. In: Bjornsti M-A, Osheroff N, editors. Methods in Molecular Biology. Totowa, New Jersey: Humana Press; 1999. Vol. 94: Protocols in DNA Topology and Topoisomerases, Part I: DNA Topology and Enzymes, pp. 99–107. PubMed

Namork E, Johansen BV. Surface activation of carbon film supports for biological electron microscopy. Ultramicroscopy. 1982;7:321–330. PubMed

Štros M, Cherny D, Jovin TM. HMG1 protein stimulates DNA end joining by promoting association of DNA molecules via their ends. Eur. J. Biochem. 2000;267:4088–4097. PubMed

Javaherian K, Liu LF, Wang JC. Nonhistone proteins HMG1 and HMG2 change the DNA helical structure. Science. 1978;199:1345–1346. PubMed

Kato J, Suzuki H, Ikeda H. Purification and characterization of DNA topoisomerase IV in Escherichia coli. J. Biol. Chem. 1992;267:25676–25684. PubMed

Dintilhac A, Bernues J. HMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences. J. Biol. Chem. 2002;277:7021–7028. PubMed

Burden DA, Osheroff N. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochem. Biophys. Acta. 1998;1400:139–154. PubMed

Robinson MJ, Osheroff N. Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II. Biochemistry. 1991;30:1807–1813. PubMed

Bromberg KD, Osheroff N. DNA cleavage and religation by human topoisomerase IIα at high temperature. Biochemistry. 2001;40:8410–8418. PubMed

Roca J, Ishida R, Berger JM, Andoh T, Wang JC. Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc. Natl Acad. Sci. USA. 1994;91:1781–1785. PubMed PMC

Ellis RJ. Macromolecular crowding: obvious but underappreciated. Trends Biochem. Sci. 2001;26:597–604. PubMed

Štros M, Reich J. Formation of large nucleoprotein complexes upon binding of the high-mobility-group (HMG) box B-domain of HMG1 protein to supercoiled DNA. Eur. J. Biochem. 1998;251:427–434. PubMed

Nagaki S, Yamamoto M, Yumoto Y, Shirakawa H, Yoshida M, Teraoka H. Non-histone chromosomal proteins HMG1 and 2 enhance ligation reaction of DNA double-strand breaks. Biochem. Biophys. Res. Commun. 1998;246:137–141. PubMed

Corbett AH, Zechiedrich EL, Lloyd RS, Osheroff N. Inhibition of eukaryotic topoisomerase II by ultraviolet-induced cyclobutane pyrimidine dimers. J. Biol. Chem. 1991;266:19666–19671. PubMed

Krasnow MA, Cozzarelli NR. Catenation of DNA rings by topoisomerases. Mechanism of control by spermidine. J. Biol. Chem. 1982;257:2687–2693. PubMed

Fortune JM, Osheroff N. Osheroff N, Bjornsti M-A. Methods in Molecular Biology. Totowa, New Jersey: Humana Press; 2001. Topoisomerase II-catalyzed relaxation and catenation of plasmid DNA. Vol. 95: DNA Topoisomerase Protocols, Part II: Enzymology and Drugs, pp. 275–281. PubMed

Polyanichko AM, Chikhirzhina EV, Skvortsov AN, Kostyleva EI, Colson P, Houssier C, Vorob’ev VI. The HMG1 ta(i)le. J. Biomol. Struct. Dyn. 2002;19:1053–1062. PubMed

Takahagi M, Tatsumi K. Aggregative organization enhances the DNA end-joining process that is mediated by DNA-dependent protein kinase. FEBS J. 2006;273:3063–3075. PubMed

Bechert T, Diekmann S, Arndt-Jovin DJ. Human 170 kDa and 180 kDa topoisomerases II bind preferentially to curved and left-handed linear DNA. J. Biomol. Struct. Dyn. 1994;12:605–623. PubMed

Sheflin LG, Fucile NW, Spaulding SW. The specific interactions of HMG 1 and 2 with negatively supercoiled DNA are modulated by their acidic C-terminal domains and involve cysteine residues in their HMG 1/2 boxes. Biochemistry. 1993;32:3238–3248. PubMed

Štros M. Two mutations of basic residues within the N-terminus of HMG-1 B domain with different effects on DNA supercoiling and binding to bent DNA. Biochemistry. 2001;17:4769–4779. PubMed

Larsen AK, Escargueil AE, Skladanowski A. Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacol. Ther. 2003;99:167–181. PubMed

Christensen MO, Larsen MK, Barthelmes HU, Hock R, Andersen CL, Kjeldsen E, Knudsen BR, Westergraad O, Boege F, et al. Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells. J. Cell Biol. 2002;157:31–44. PubMed PMC

Völp K, Brezniceanu M-L, Bösser S, Brabletz T, Kirchner T, Göttel D, Joos S, Zörnig M. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut. 2006;55:234–242. PubMed PMC

Depowski PL, Rosenthal SI, Brien TP, Stylos S, Johnson RL, Ross JS. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables. Mod. Pathol. 2000;13:542–547. PubMed

Watanuki A, Ohwada S, Fukusato T, Makita F, Yamada T, Kikuchi A, Morishita Y. Prognostic significance of DNA topoisomerase IIalpha expression in human hepatocellular carcinoma. Anticancer Res. 2002;22:1113–1119. PubMed

Histone H1 Differentially Inhibits DNA Bending by Reduced and Oxidized HMGB1 Protein

HMGB1 gene knockout in mouse embryonic fibroblasts results in reduced telomerase activity and telomere dysfunction

Cruciform structures are a common DNA feature important for regulating biological processes

HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha